Nicolas Villain

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Mass Spectrometry

Amyotrophic Lateral Sclerosis

Top Venues

Brain communications

Nature reviews. Neurology

European journal of neurology

Journal of neural transmission (Vienna, Austria : 1996)

This page only lists publications with an associated author ORCID identifier.

Publications

Nicolas Villain, Robin Michalon
What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries. European journal of neurology (2024)
Nicolas Villain, Vincent Planche
Disentangling clinical and biological trajectories of neurodegenerative diseases. Nature reviews. Neurology (2024)
Kathy Y Liu, Nicolas Villain, Scott Jonathan Ayton, Sarah F Ackley, Vincent Planche, Robert Howard, Madhav Thambisetty
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease. Brain communications 5 (3) (2023)
Kathy Y Liu, Nicolas Villain, Scott Jonathan Ayton, Sarah F Ackley, Vincent Planche, Robert Howard, Madhav Thambisetty
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease. Brain communications 5 (3) (2023)
Kathy Y Liu, Nicolas Villain, Scott Jonathan Ayton, Sarah F Ackley, Vincent Planche, Robert Howard, Madhav Thambisetty
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease. Brain communications 5 (3) (2023)
Laura Xicota, Beata Gyorgy, Benjamin Grenier-Boley, Alexandre Lecoeur, GaÃ Lle Fontaine, Fabrice Danjou, Jorge Samper Gonzalez, Olivier Colliot, Phillippe Amouyel, Garance Martin, Marcel Levy, Nicolas Villain, Marie-Odile Habert, Bruno Dubois, Jean-Charles Lambert, Marie-Claude Potier, null null
Association of APOE-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults. Neurology (2022)
Rita Azevedo, Chloé Jacquemin, Nicolas Villain, François Fenaille, Foudil Lamari, François Becher
Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications. Cells 11 (8) (2022)
Claire Pujol, Anne Legrand, Livia Parodi, Priscilla Thomas, Fanny Mochel, Dario Saracino, Giulia Coarelli, Marijana Croon, Milica Popovic, Manon Valet, Nicolas Villain, Shahira Elshafie, Mahmoud Y Issa, Stéphane Zuily, Mathilde Renaud, Cécilia Marelli-Tosi, Marine Legendre, Aurélien Trimouille, Isabelle Kemlin, Sophie Mathieu, Joseph G Gleeson, Foudil Lamari, Daniele Galatolo, Rana Alkouri, Chantal Tse, Diana Rodriguez, Claire Ewenczyk, Florence Fellmann, Thierry Kuntzer, Emilie Blond, Khalid Hamid El Hachimi, Frédéric Darios, Alexandre Seyer, Anastasia D Gazi, Patrick Giavalisco, Silvina Perin, Jean-Luc Boucher, Laurent Le Corre, Filippo Maria Santorelli, Cyril Goizet, Maha Saad Zaki, Serge Picaud, Arnaud Mourier, Sophie Marie Steculorum, Mignot Cyril, Alexandra Dürr, Aleksandra Trifunovic, Giovanni Stevanin
Implication of folate deficiency in CYP2U1 loss of function. The Journal of experimental medicine 218 (11) (2021)
Nicolas Villain, G Béra, M-O Habert, A Kas, J Aubert, O Jaubert, R Valabregue, S Fernandez-Vidal, J-C Corvol, G Mangone, S Lehéricy, M Vidailhet, D Grabli, null null
Dopamine denervation in the functional territories of the striatum: a new MR and atlas-based 123I-FP-CIT SPECT quantification method. Journal of neural transmission (Vienna, Austria : 1996) 128 (12) (2021)
Nicolas Villain, Bruno Dubois
Alzheimer's Disease Including Focal Presentations. Seminars in neurology 39 (2) (2019)